The reduction in the price target by Wells Fargo, a major financial institution, could lead to a negative short-term sentiment among investors, potentially causing a decrease in CVS Health's stock price. The Equal-Weight rating suggests that the stock is expected to perform in line with the market, but the lowered price target indicates a revision of the expected stock value.